Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells.

Technology
E-129-2001
Patent ID
E-129-2001-0-EP-04
Country
EP
Application Type
National Stage
Patent Status
Expired
Patent Number
 
Publication Number
1448584
Application Number
02761818.0
IC
NCI
Date Filed
Date Issued
Patent PDF